CELU Celularity Inc. - Class A

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.

$3.22  -0.39 (-10.80%)
As of 06/28/2022 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  08/08/2019
Outstanding shares:  138,311,074
Average volume:  934,994
Market cap:   $508,984,752
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -30.00
PB ratio:   5.64
PS ratio:   18.66
Return on equity:   -181.29%
Net income %:   -597.67%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy